GCP
KYMR icon

GSA Capital Partners’s Kymera Therapeutics KYMR Stock Holding History

GSA Capital Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$842K Sell
7,343
-5,314
-42% -$457K 0.05% 619
2026
Q1 		$1.05M Buy
+12,657
New +$1M 0.07% 468
2025
Q4 		– Sell
-5,137
Closed -$291K – 1901
2025
Q3 		$291K Buy
+5,137
New +$232K 0.02% 1214
2025
Q2 		– Sell
-31,537
Closed -$863K – 1959
2025
Q1 		$863K Buy
31,537
+1,997
+7% +$72.8K 0.08% 437
2024
Q4 		$1.19M Buy
29,540
+8,058
+38% +$364K 0.09% 296
2024
Q3 		$1.02M Sell
21,482
-6,051
-22% -$267K 0.08% 459
2024
Q2 		$822K Buy
27,533
+15,888
+136% +$550K 0.06% 639
2024
Q1 		$468K Sell
11,645
-10,931
-48% -$391K 0.04% 923
2023
Q4 		$575K Sell
22,576
-28,512
-56% -$510K 0.05% 705
2023
Q3 		$710K Buy
51,088
+29,904
+141% +$601K 0.06% 583
2023
Q2 		$487K Buy
+21,184
New +$607K 0.05% 758
2023
Q1 		– Sell
-13,301
Closed -$332K – 1713
2022
Q4 		$332K Buy
13,301
+1,293
+11% +$34.5K 0.04% 869
2022
Q3 		$261K Sell
12,008
-17,914
-60% -$472K 0.03% 1022
2022
Q2 		$589K Buy
29,922
+23,920
+399% +$559K 0.09% 393
2022
Q1 		$254K Sell
6,002
-21,670
-78% -$915K 0.03% 1019
2021
Q4 		$1.76M Buy
+27,672
New +$1.61M 0.22% 41

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

GSA Capital Partners's KYMR Position: Q2 2026 in Review

GSA Capital Partners reduced its Kymera Therapeutics (KYMR) stake by 42% in Q2 2026, selling an estimated $457K and leaving 7,343 shares worth $842K. The position accounts for 0.05% of the portfolio, ranked #619.

GSA Capital Partners first reported a position in KYMR in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.76M in Q4 2021. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • GSA Capital Partners held 7,343 shares of Kymera Therapeutics worth $842K as of Q2 2026.
  • GSA Capital Partners sold 5,314 Kymera Therapeutics shares in Q2 2026, an estimated $457K.
  • Kymera Therapeutics made up 0.05% of GSA Capital Partners's portfolio in Q2 2026, its #619 holding.
  • GSA Capital Partners first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • GSA Capital Partners's Kymera Therapeutics position peaked at $1.76M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.